Become a Member

tomstender

Microblogs

Recent Author Comments

On Yastine's "$5 Biotech Stock Revolutionizing Health Care"

Can’t compete with private unicorn, INTARCIA, WHO HAS A MEDICAL IMPLANT DEVICE THAT ONLY HAS TO BE RELOADED ONCE A YEAR. THEY CURRENTLY USE EXENATIDE, A GLP-1 type two diabetes drug.[...]

Go to Comment »

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info